SHP-1 is a target of regorafenib in colorectal cancer

Regorafenib is an inhibitor of multiple protein kinases which exerts antitumor and antimetastatic activities in metastatic colorectal cancer (CRC). SH2 domain-containing phosphatase 1 (SHP-1) is reported to have tumor suppressive potential because it acts as a negative regulator of p-STAT3(Tyr705) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Li-Ching, Teng, Hao-Wei, Shiau, Chung-Wai, Lin, Hang, Hung, Man-Hsin, Chen, Yen-Lin, Huang, Jui-Wen, Tai, Wei-Tien, Yu, Hui-Chuan, Chen, Kuen-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171626/
https://www.ncbi.nlm.nih.gov/pubmed/25071018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171626/
https://www.ncbi.nlm.nih.gov/pubmed/25071018

Ejemplares similares